Ryvyl Inc.RVYLNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank85
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P85
Within normal range
vs 2Y Ago
6.1x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q3 202567.44%
Q2 2025-71.27%
Q1 2025-45.31%
Q4 20240.74%
Q3 2024-0.49%
Q2 2024-41.21%
Q1 20245.29%
Q4 20230.61%
Q3 202311.06%
Q2 2023-38.84%
Q1 202398.36%
Q4 2022-32.32%
Q3 2022-24.90%
Q2 2022-0.93%
Q1 202241.97%
Q4 202130.83%
Q3 202129.10%
Q2 202123.70%
Q1 202115.52%
Q4 2020131.88%
Q3 2020-8.88%
Q2 2020-6.58%
Q1 202068.56%
Q4 2019-55.39%
Q3 2019-36.51%
Q2 2019477.61%
Q1 201916.83%
Q4 2018-28.78%
Q3 201818.72%
Q2 201881.94%
Q1 2018-46.55%
Q4 20173791.01%
Q3 20170.00%
Q2 20170.00%
Q1 20170.00%
Q4 20160.00%
Q3 20160.00%
Q2 20160.00%
Q1 20160.00%
Q4 20150.00%